CLOVER HEALTH INVESTMENTS, CORP.

(CLOV)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
3.260 USD   +9.76%
08/03Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022
AQ
07/26Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GL
07/26Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GL
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/01/2022 08/02/2022 08/03/2022 08/04/2022 08/05/2022 Date
2.92(c) 3.1(c) 3.08(c) 2.97(c) 3.26(c) Last
6 209 483 9 283 311 7 410 965 6 833 507 10 441 706 Volume
+4.29% +6.16% -0.65% -3.57% +9.76% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 3 306 M - -
Net income 2022 -361 M - -
Net cash position 2022 108 M - -
P/E ratio 2022 -4,16x
Yield 2022 -
Sales 2023 4 190 M - -
Net income 2023 -292 M - -
Net cash position 2023 305 M - -
P/E ratio 2023 -5,29x
Yield 2023 -
Capitalization 1 535 M 1 535 M -
EV / Sales 2022 0,43x
EV / Sales 2023 0,29x
Nbr of Employees 680
Free-Float 69,9%
More Financials
Company
Clover Health Investments, Corp. is a healthcare technology company. The Company’s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Company’s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is... 
More about the company
Ratings of Clover Health Investments, Corp.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about CLOVER HEALTH INVESTMENTS, CORP.
08/03Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 1..
AQ
07/26Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GL
07/26Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GL
07/26Clover Health Investments, Corp. Appoints Scott J. Leffler as its Chief Financial Offic..
CI
07/26CLOVER HEALTH INVESTMENTS, CORP. /DE : Change in Directors or Principal Officers, Financia..
AQ
07/26Dr. Carladenise Armbrister Edwards Joins Clover Health Board of Directors
GL
07/26Clover Health Investments, Corp. Announces Appointment of Carladenise Armbrister Edward..
CI
07/14Clover Health Investments Plans Medicare Advantage Expansion
MT
07/14Clover Health Announces Planned Medicare Advantage Expansion for 2023
GL
07/11Clover Health to Report Second Quarter 2022 Financial Results on August 8, 2022
AQ
06/24Clover Health Investments to Join Russell 3000 Index on June 27
MT
06/24Clover Health Set to Join Russell 3000® Index
AQ
06/24CLOVER HEALTH INVESTMENTS, CORP.(NAS : CLOV) added to Russell Small Cap Completeness Index
CI
06/24CLOVER HEALTH INVESTMENTS, CORP.(NAS : CLOV) added to Russell 2000 Dynamic Index
CI
06/24CLOVER HEALTH INVESTMENTS, CORP.(NAS : CLOV) added to Russell 3000E Index
CI
More news
News in other languages on CLOVER HEALTH INVESTMENTS, CORP.
07/26Clover Health Investments, Corp. annonce la nomination de Carladenise Armbrister Edward..
07/14Clover Health Investments prévoit l'expansion de Medicare Advantage
06/24Clover Health Investments rejoindra l'indice Russell 3000 le 27 juin prochain
05/27Clover Health Investments, Corp. annonce la démission de Nathaniel S. Turner comme memb..
05/25Clover Health Investments nomme Scott Leffler au poste de directeur financier
More news
Analyst Recommendations on CLOVER HEALTH INVESTMENTS, CORP.
More recommendations
Chart CLOVER HEALTH INVESTMENTS, CORP.
Duration : Period :
Clover Health Investments, Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CLOVER HEALTH INVESTMENTS, CORP.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 3,26 $
Average target price 3,58 $
Spread / Average Target 9,92%
EPS Revisions
Managers and Directors
Vivek Garipalli Chairman & Chief Executive Officer
Andrew Toy President & Director
Scott J. Leffler Chief Financial & Accounting Officer
Sophia Chang Chief Clinical Informatics Officer
Kumar Dharmarajan Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
CLOVER HEALTH INVESTMENTS, CORP.-12.37%1 535
VEEVA SYSTEMS INC.-11.03%35 197
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-27.92%8 175
OMNICELL, INC.-38.65%4 823
PRO MEDICUS LIMITED-13.61%3 877
SECTRA AB (PUBL)-10.44%3 393